The role of viral mutation in the pathogenesis of chronic viral hepatitis
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The quasispecies nature of hepatitis B and C virus (HBV, HCV) plays an important role in the pathogenesis, immune escape and drug resistance during chronic infection. Although there is still a lack of effective treatment for hepatitis C, a series of nucleoside analogs (NA) have been developed for the treatment of hepatitis B. NA resistant HBV mutants can accumulate during prolonged therapy and lead to the failure of anti-HBV therapy. Switching to other sensitive NAs can inhibit the emerged resistant mutants. Therefore, understanding the evolution of viral quasispecies under drug pressure is crucial for the establishment of antiviral strategy and the monitoring of antiviral process. Immune response and escape are complicated process, during which both host and virus factors may play their roles. Further understanding of the interaction and interrelationship between host and these viruses may lead to optimized prevention, diagnosis and treatment for chronic hepatitis.
- Allen M I, Deslauriers M, Andrews C W, et al. 1998. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology, 27: 1670–1677. CrossRef
- Bartholomeusz A, Locarnini S. 2006 Hepatitis B virus mutations associated with antiviral therapy. J Med Virol, 78(Suppl 1): S52–S55. CrossRef
- Baumert T F, Rogers S A, Hasegawa K, et al. 1996. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest, 98:2268–2276. CrossRef
- Baumert T F, Yang C, Schurmann P, et al. 2005. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes. Hepatology, 41: 247–256. CrossRef
- Blackberg J, Kidd-Ljunggren K. 2003. Mutations within the hepatitis B virus genome among chronic hepatitis B patients with hepatocellular carcinoma. J Med Virol, 71: 18–23. CrossRef
- Blum H E. 1993. Hepatitis B virus: significance of naturally occurring mutants. Intervirology, 35: 40–50.
- Domingo E, Gonzalez-Lopez C, Pariente N, et al. 2005. Population dynamics of RNA viruses: the essential contribution of mutant spectra. Arch Virol. (Suppl); 59–71.
- Farci P, Quinti I, Farci S, et al. 2006. Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proc Natl Acad Sci USA, 103: 8475–8480. CrossRef
- Lok A S, McMahon B J. 2004. Chronic hepatitis B: update of recommendations. Hepatology, 39: 857–861. CrossRef
- Lok A S, McMahon B J. 2007. Chronic hepatitis B. Hepatology, 45: 507–539. CrossRef
- Martin V, Perales C, Davila M, et al. 2006. Viral fitness can influence the repertoire of virus variants selected by antibodies. J Mol Biol, 362: 44–54. CrossRef
- Milich D R, Jones J E, Hughes J L, et al. 1990. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA, 87: 6599–6603. CrossRef
- Ogata N, Miller R H, Ishak K G, et al. 1993. The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. Virology, 194: 263–276. CrossRef
- Pallier C, Castera L, Soulier A, et al. 2006. Dynamics of hepatitis B virus resistance to lamivudine. J Virol, 80: 643–653. CrossRef
- Ray S C, Mao Q, Lanford R E, et al. 2000. Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J Virol, 74:3058–3066. CrossRef
- Ray S C, Wang Y M, Laeyendecker O, et al. 1999. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J Virol, 73: 2938–2946.
- Wang Y M, Ray S C, Laeyendecker O, et al. 1998. Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs. J Clin Microbiol, 36: 2982–2989.
- Yamada G, Takaguchi K, Matsueda K, et al. 1990. Immunoelectron microscopic observation of intrahepatic HBeAg in patients with chronic hepatitis B. Hepatology, 2: 133–140. CrossRef
- Yim H J, Hussain M, Liu Y, et al. 2006. Evolution of multi-drug resistant hepatitis B virus during sequential therapy. Hepatology, 44: 703–712. CrossRef
- The role of viral mutation in the pathogenesis of chronic viral hepatitis
Volume 23, Issue 2 , pp 132-136
- Cover Date
- Print ISSN
- Online ISSN
- SP Wuhan Institute of Virology, CAS
- Additional Links
- Hepatitis B virus
- Antiviral therapy